Strontium and ciprofloxacin modified hydroxyapatites as functional grafts for bone prostheses
Source abstract
Abstract
Abstract Both strontium and ciprofloxacin are known to be functional materials for the treatment of bone diseases associated to the loss of bone substance. In this work we prepared the strontium (Sr) modified hydroxyapatite (SrHA) and ciprofloxacin (Cip) modified SrHA bone substitutes by one pot facile chemical precipitation route. The calcium release is improved more for SrHA compared with stoichiometric HA owing to the higher solubility of the Sr. Drug release profile exhibited the sustained and prolonged release of Cip up to 45 days. The in-vitro cell responses showed that the Sr addition improved the ALP activity of the osteoblast like MG-63 cells which confirms the enhanced cell viability and functionality of the strontium modified hydroxyapatite ceramics.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Hydroxyapatite bone substitutes developed via replication of natural marine sponges
2. Nanometre scale hydroxyapatite ceramics for bone tissue engineering
3. Design and characterization of calcium phosphate ceramic scaffolds for bone tissue engineering10.1016/j.dental.2015.09.008 ↗
4. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration10.1016/j.bone.2004.10.004 ↗
5. In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads10.1016/S0939-6411(00)00150-8 ↗
6. Strontium modified calcium phosphate cements – approaches towards targeted stimulation of bone turnover 10.1039/C5TB00654F ↗
7. Strontium and zinc co-substituted nanophase hydroxyapatite10.1016/j.ceramint.2017.06.062 ↗
8. Substituted hydroxyapatites for biomedical applications: a review10.1016/j.ceramint.2015.03.316 ↗
9. Substituted hydroxyapatites for bone regeneration: a review of current trends10.1002/jbm.b.33651 ↗
10. Cationic and anionic substitutions in hydroxyapatite
11. Effects of strontium in modified biomaterials10.1016/j.actbio.2010.08.031 ↗
12. Fibrous growth of strontium substituted hydroxyapatite and its drug release10.1016/j.msec.2010.11.025 ↗
13. Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite10.1016/j.biomaterials.2006.11.001 ↗
14. A novel injectable bioactive bone cement for spinal surgery: a developmental and preclinical study10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R ↗
15. A novel strontium(II)-modified calcium phosphate bone cement stimulates human-bone-marrow-derived mesenchymal stem cell proliferation and osteogenic differentiation in vitro10.1016/j.actbio.2013.07.027 ↗
16. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro10.1016/j.biomaterials.2010.01.121 ↗
17. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age10.1016/j.bone.2009.12.006 ↗
18. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages10.1016/j.bone.2005.10.030 ↗
19. Strontium hydroxyapatite/chitosan nanohybrid scaffolds with enhanced osteoinductivity for bone tissue engineering10.1016/j.msec.2016.11.063 ↗
20. T. Shunmugaperumal, Chapter 1 – Biofilm Eradication and Prevention: A Pharmaceutical Approach to Medical Device Infections, 2010.10.1002/9780470640463 ↗
21. FTIR and XRD evaluation of carbonated hydroxyapatite powders synthesized by wet methods10.1016/j.molstruc.2004.11.078 ↗
22. Effect of gelatin on the in situ formation of alginate/hydroxyapatite nanocomposite10.1016/j.matlet.2012.09.054 ↗
23. Simultaneous crystallization of calcium phosphate and calcium oxalate in the presence of ascorbic acid under physiological conditions10.1016/j.msec.2008.09.030 ↗
24. Kefiran-alginate gel microspheres for oral delivery of ciprofloxacin10.1016/j.colsurfb.2016.05.078 ↗
25. Tailor made alginate hydrogel for local infection prophylaxis in orthopedic applications10.1016/j.msec.2017.04.154 ↗
26. Sr-substituted hydroxyapatites for osteoporotic bone replacement10.1016/j.actbio.2007.05.006 ↗
27. Development and characterization of biphasic hydroxyapatite/β-TCP cements10.1111/jace.12861 ↗
28. Simultaneous crystallization of calcium phosphate and calcium oxalate in the presence of ascorbic acid under physiological conditions10.1016/j.msec.2008.09.030 ↗
29. ISO, 10993-5 – Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity, 2009.